Exfoliative dermatitis
Chapter 12:Diseases of the skin and subcutaneous tissue
ICD-10 L26 is a billable code used to indicate a diagnosis of exfoliative dermatitis.
Exfoliative dermatitis is a severe skin condition characterized by widespread redness, scaling, and shedding of the skin. It can affect large areas of the body and may be associated with systemic symptoms such as fever, chills, and malaise. The condition can arise from various underlying causes, including drug reactions, infections, or pre-existing skin diseases like psoriasis or eczema. The skin's anatomy involved includes the epidermis, which becomes inflamed and hyperproliferative, leading to the characteristic exfoliation. Disease progression can vary; in some cases, it may resolve with treatment of the underlying cause, while in others, it can lead to significant complications such as secondary infections or fluid loss. Diagnostic considerations include a thorough patient history, physical examination, and potentially skin biopsies to rule out other dermatological conditions. Laboratory tests may also be necessary to identify systemic involvement or underlying causes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L26 covers exfoliative dermatitis, which can be triggered by various factors including drug reactions, infections, and pre-existing skin conditions. It is essential to identify the underlying cause to provide appropriate treatment.
L26 should be used when there is a clear presentation of exfoliative dermatitis with systemic symptoms or when the condition is severe enough to warrant specific treatment. It is differentiated from other dermatitis codes by its extensive skin involvement and potential systemic effects.
Documentation should include a detailed patient history, physical examination findings, treatment plans, and any laboratory or biopsy results that support the diagnosis of exfoliative dermatitis.
